Amn107



Indications and Reactions:

Role Indications Reactions
Primary
Chronic Myeloid Leukaemia 35.5%
Prophylaxis 11.7%
Hypertension 9.8%
Diabetes Mellitus 8.5%
Upper Respiratory Tract Infection 4.8%
Constipation 3.4%
Pruritus 3.4%
Insomnia 2.9%
Pain 2.4%
Gastrointestinal Stromal Tumour 2.3%
Asthma 2.1%
Abdominal Pain 1.9%
Gastroenteritis 1.9%
Rash 1.9%
Nasopharyngitis 1.8%
Depression 1.2%
Diarrhoea 1.2%
Dyspepsia 1.2%
Hypercholesterolaemia 1.1%
Nausea 1.1%
Thrombocytopenia 12.7%
Vomiting 9.5%
Myocardial Infarction 6.7%
Angina Pectoris 6.3%
Lipase Increased 5.6%
Pyrexia 5.6%
Coronary Artery Disease 4.8%
Electrocardiogram Qt Prolonged 4.8%
Rash 4.8%
Upper Respiratory Tract Infection 4.8%
Chest Pain 4.4%
Gamma-glutamyltransferase Increased 4.0%
Myocardial Ischaemia 3.6%
Nausea 3.6%
Syncope 3.6%
Dyspnoea 3.2%
Pruritus 3.2%
Stent Placement 3.2%
White Blood Cell Count Decreased 3.2%
Acute Myocardial Infarction 2.8%
Secondary
Chronic Myeloid Leukaemia 29.5%
Prophylaxis 16.8%
Diabetes Mellitus 9.1%
Hypertension 6.2%
Constipation 5.0%
Back Pain 4.4%
Upper Respiratory Tract Infection 4.3%
Abdominal Pain 4.2%
Pain 3.1%
Rash 2.1%
Insomnia 2.0%
Eczema 1.7%
Pruritus 1.6%
Anaesthesia 1.6%
Nausea 1.6%
Neurotoxicity 1.6%
Gastritis 1.5%
Hyperlipidaemia 1.4%
Dysuria 1.3%
Folliculitis 1.2%
Subdural Haematoma Evacuation 12.5%
Thrombocytopenia 9.3%
Vomiting 7.1%
Vascular Graft 6.8%
Platelet Count Decreased 6.2%
Weight Decreased 6.2%
White Blood Cell Count Decreased 6.2%
Pruritus 5.9%
Gamma-glutamyltransferase Increased 4.5%
Lipase Increased 4.5%
Upper Respiratory Tract Infection 3.7%
Pulmonary Oedema 3.4%
Subdural Haematoma 3.4%
Wheezing 3.1%
Angina Pectoris 2.8%
Blood Bilirubin Increased 2.8%
Blood Glucose Increased 2.8%
Hyperbilirubinaemia 2.8%
Pyrexia 2.8%
Rash 2.8%
Concomitant
Chronic Myeloid Leukaemia 100.0%
Surgery 100.0%
Interacting
Acute Lymphocytic Leukaemia 25.0%
Diabetes Mellitus 25.0%
Epididymitis 25.0%
Oesophagitis 25.0%
Drug Interaction 100.0%